(January 29, 2020, 2:06 PM EST) -- NEW YORK — The Federal Trade Commission and the New York attorney general on Jan. 27 sued “Pharma Bro” Martin Shkreli and the drug companies he allegedly continues to run from his federal prison cell for violating federal and state antitrust laws by blocking generic competition for the drug Daraprim (Federal Trade Commission, et al. v. Vyera Pharmaceuticals, LLC, et al., No. 20-cv-706, S.D. N.Y.)....